Literature DB >> 31388418

Feasibility and safety of reduced-port video-assisted thoracoscopic surgery using a needle scope for pulmonary lobectomy- retrospective study.

Masato Aragaki1, Kichizo Kaga1, Yasuhiro Hida1, Tatsuya Kato1, Yoshiro Matsui1.   

Abstract

BACKGROUND: This study aimed to determine the usefulness and limitations of videoassisted thoracoscopic (VATS) lobectomy using one-window and puncture method (1WPM).
METHODS: This study involved 14 patients who underwent lobectomy using the 1WPM at our institute from 2008 to 2017.
RESULTS: The study patients comprised of 3 men and 11 women with a median age of 10.5 years (range, 0-72 years). There were eight cases in children younger than 18 years old and the youngest patient was 9 days old. The diagnoses were congenital pulmonary cystic disease (n = 7), primary lung cancer (n = 4), metastatic lung tumor (n = 1), and others (n = 2). The 1WPM was successful in 9 of 14 patients (64.3%) and, in 5 cases (35.7%), needed conversion to either two-window method (TWM) using additional port (n = 3) or open thoracotomy (n = 2). The causes for conversion were need for additional bronchoplasty or lymph node dissection (n = 3), failure of one-lung ventilation (n = 1), and presence of a small thoracic cavity that made the procedure extremely difficult (n = 1). In the group that was successfully treated with 1WPM, the median values were as follows: operation time, 193 min (range, 112-480 min); blood loss, 0 ml (range, 0-90 ml); drainage duration, 1 day (range, 1-4 days); and postoperative hospital stay, 7 days (range, 4-13 days).
CONCLUSIONS: Lobectomy by 1WPM can be safely performed and has good postoperative course and this procedure can be applicable and effective in small infants.

Entities:  

Keywords:  Congenital pulmonary cystic disease; One-window and puncture method; Reduced port surgery; Video-assisted thoracoscopic surgery

Year:  2019        PMID: 31388418      PMCID: PMC6677861          DOI: 10.1016/j.amsu.2019.07.027

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


Introduction

Since its initial introduction in the early 1990s [1,2], video-assisted thoracoscopic surgery (VATS) has become the standard procedure for pulmonary lobectomy. Recently, surgeries minimizing invasiveness have been developed including reduced-port surgery, which includes uniportal incision [[3], [4], [5], [6], [7]], two-port access [[8], [9], [10]], and needlescopic VATS [11]. However, there are few reports discussing limitations and indications for each procedure [12,13]. We use two standard approaches in VATS for lobectomy in lung disease: one approach, the two-window method (TWM), which uses two ports along the posterolateral incision line [8], or the one-window and puncture method (1WPM), which uses one-port access and a needle scope [11]. This study focused on the 1WPM during VATS for pulmonary lobectomy to determine its usefulness and limitations, and evaluated its feasibility and safety.

Methods

Patients

This retrospective, single-center study included data from 14 subjects who underwent pulmonary lobectomy by VATS using the 1WPM at our institute between 2008 and 2017. Written informed consent was obtained from all patients. Patients who did not require lymph node dissection and met provisional indications were selected for the 1WPM. Conventional TWM, following our standard institutional approach, or standard thoracotomy were used when the 1WPM was not feasible and these patients were excluded from the study. We examined sbackground factors, including age, sex, height, body weight, BMI, laterality of surgery, surgical objective, target, location, and operative procedure to determine the appropriateness of provisional indications. The information was retrieved from our hospital database and the study did not require approval by any ethics boards. The study was reported in line with the STROCSS criteria [12]. This study was registered with Researchregistry.com (ID no: researchregistry 4882).

Statistical analyses

Descriptive statistics were reported as median (range), and categorical data were reported as percentages (%). Statistical analyses were performed using JMP software (SAS Institute, Cary, North Carolina, USA).

Surgical technique

Surgery was performed under general anesthesia using one-lung ventilation. For the 1WPM, a 2–4 cm incision was made on the anterior or posterior midaxillary line of the fifth or sixth intercostal space (Fig. 1, Fig. 2). An Alexis wound retractor XSTM (Applied Medical, Rancho Santa Margarita, CA, USA) or LAPPROTECTORTM mini-mini (Hakko medical, Tokyo, Japan) was used during thoracotomy. A 30° rigid scope measuring 3 mm or 5 mm in diameter (Olympus Medical Science, Tokyo, Japan) permitted intrathoracic observation to confirm the indications for the 1WPM. An additional puncture was made for the needle scope if insertion through the initial incision site was insufficient. Surgical procedures were occasionally assisted by the pulling method using silk or needle forceps through additional puncture points (Fig. 3). The resected specimen was placed in a plastic bag and extracted. After confirming the absence of air leakage using a sealing test, 12–20 Fr drainage tubes were inserted to complete the surgery.
Fig. 1

Skin incision of the 1WPM technique (A) Left lower lobectomy in an adult patient; (B) right lower lobectomy in a pediatric patient. 1WPM.

Fig. 2

Postoperative results of the 1WPM 1WPM.

Fig. 3

Intraoperative image of the 1WPM for a left lower lobectomy. (A)Encircling of the pulmonary artery (A8); (B) Encircling of inferior pulmonary vein; (C) View after bronchial stump cutting; (D) Surgical wound immediately after surgery. 1WPM.

Skin incision of the 1WPM technique (A) Left lower lobectomy in an adult patient; (B) right lower lobectomy in a pediatric patient. 1WPM. Postoperative results of the 1WPM 1WPM. Intraoperative image of the 1WPM for a left lower lobectomy. (A)Encircling of the pulmonary artery (A8); (B) Encircling of inferior pulmonary vein; (C) View after bronchial stump cutting; (D) Surgical wound immediately after surgery. 1WPM.

Results

Patient characteristics and clinical findings are shown in Table 1. The cohort of 14 patients included 3 men and 11 women with a median age of 10.5 years (range, 0–72 years). At the time of surgery, the median height was 124.5 cm (range, 48–166 cm) and the median weight was 30.5 kg (range, 2.6–76.9 kg). The diagnoses were congenital pulmonary cystic disease (n = 7), primary lung cancer (n = 4), metastatic lung tumor (n = 1), pulmonary sclerosing hemangioma (n = 1), and non-tuberculous mycobacterial infection (n = 1).
Table 1

Patient characteristics.

CharacteristicNumber
Number of patients
Sex
 Male3
 Female11
Age (years)
 Median (Range)10.5 (0–72)
 <18 years8
 ≧18 years, <40 years1
 ≧40 years5
Height (cm)
 Median (Range)124.5 (48–166)
Weight (kg)
 Median (Range)30.5 (2.6–76.9)
Disease
 Congenital pulmonary airway malfunctions7
 Primary lung cancer4
 Metastatic lung tumor1
 Pulmonary sclerosing hemangioma1
 Nontuberculous mycobacterial infection1
Patient characteristics. The surgical procedures were middle lobectomy (n = 5), left lower lobectomy (n = 4), right lower lobectomy (n = 3), and left upper lobectomy (n = 2) (Table 2). The median operative time was 199.5 min (range, 112–507 min) with an estimated blood loss of 0 ml (range, 0–90 ml). The median duration of drainage was 1.5 days (range, 1–7 days), and the median length of hospitalization was 7 days (range, 4–20 days). The 1WPM was completed in 9 cases (64.3%). Five cases (35.7%) required conversion to TWM or thoracotomy (Table 3). Three patients required additional bronchoplasty or lymph node dissection. In two patients, unexpected procedural conversion was related to failure of one-lung ventilation or a small thoracic cavity that made the procedure difficult. No other patients developed major complications.
Table 2

Operation procedure.

CaseLesionoperation time (min)bleeding (ml)ConversionDrainage (days)hospital stay (days)
1RLL1930-413
2RLL1420-14
3RML19550-14
4RML20420Conversion17
5RML1890-17
6LLL1620-16
7RLL48090-29
8LLL3160Conversion27
9LUL5070Conversion320
10RML4140-211
11LUL50750Conversion17
12LLL44130Conversion17
13RML1390-25
14
LLL
112
0
-
2
5
Median199.501.57
Table 3

Characteristics of conversion cases.

CaseAge, yearsSexHeight, cmWeight, kgDiagnosisLesionoperation time, minbleeding, mlConversion typeReasons for conversion
458M16676.9metastatic lung tumorRML20420Thoracotomyneed for bronchoplasty
863F15950.7primary lung cancerLLL3160TWMneed for lymph node dissection
90(9days)F482.6CPAMLUL5070Thoracotomya small thoracic cavity
115M9913.4CPAMLUL50750TWMfailure of one lung ventilation
1224F14847.7primary lung cancerLLL44130TWMneed for lymph node dissection
Operation procedure. Characteristics of conversion cases.

Discussion

VATS for pulmonary lobectomy was conventionally performed using three or more ports. However, reduced-port surgeries including uniportal VATS and 1WPM have gained interest worldwide. However, these reduced-port procedures are technically demanding, and have issues, such as learning curve, safety, adaptation, and limitations [6,7,[13], [14], [15], [16], [17]]. We have used reduced-port surgery by TWM for pulmonary lobectomy since 2007. With the aim of further decreasing invasiveness, we selected cases from 2008 to 2017 and performed pulmonary lobectomy by the 1WPM. In this study, it was not feasible to compare the outcomes of pulmonary lobectomy between the 1WPM and other procedures because no patients underwent the conventional method without lymph node dissection. The operative time, blood loss, drainage time, length of hospitalization, and postoperative complications in this study were similar to those reported for the conventional methods and were generally acceptable [6,7,[13], [14], [15]]. The rate of conversion from uniportal VATS lobectomy to open surgery is reported to range from 2% to 23% [6,7,18,19]. In this study, the conversion rate was 35.7% largely due to the necessity for additional procedures such as bronchoplasty and lymph node dissection. Two cases, both of which were pediatric patients, were converted due difficulties during surgery. Therefore, it is necessary to consider not only technical reasons, but also factors such as small physique. Although the number of cases in this study was small, none required emergency thoracotomy due to complications. Overall, these data suggest that surgery by 1WPM can be performed safely. Reduced-port surgery is important to not only reduce wound pain, blood loss, and operation time, but to also to potentially increase curability. Improvements in long-term results, including recurrence rate of malignant tumors are necessary, but have yet to be analyzed in this context. Lymph node dissection using the 1WPM is technically possible, but since it has not been confirmed whether lymph node dissection during reduced-port surgery effects the survival rate of patients with malignant tumors, it has not been adopted in clinical practice. We believe that medium-to long-term observations after reduced-port surgery with lymph node dissection are needed to evaluate the effects on survival rate of patients with malignant tumors before implementation in the clinic. Both 1WPM and uniportal VATS are included in the category of reduced-port surgery, but there are several differences between the two. Uniportal VATS entails insertion of both the camera and forceps from one direction, requiring ingenuity in creating the visual field and preparation of special instruments. The 1WPM is performed with three-port VATS or the TWM instrument, eliminating the need to prepare special instruments, which has the merit of being easy to introduce to other facilities. Second, a 3-mm port can be inserted at the optimal position without limit and serve as a camera for confirmation of the surgical field in the 1WPM. Surgical invasiveness with the 3-mm port is minor because the wound does not need suturing, produces minimal scarring, and minimizes pain. Moreover, the necessary incision length for extraction of the resected specimen is only 35 mm, and the total incision length is less than 40 mm. In children who have smaller lungs, this incision length is approximately 25 mm. The applicability of the 1WPM for pediatric patients, in whom thoracoscopic surgery is technically difficult due to their smaller physique and working space, is also an advantage. Small size makes VATS lobectomy difficult in children and often requires a special approach; therefore, this operation is performed at only a few facilities [20,21]. Since the surgical instruments for both procedures are the same, surgeons can learn the technique of normal VATS lobectomy before doing the 1WPM in adults. The 1WPM can then be applied to pediatric cases once surgeons become proficient. However, the applicability of 1WPM in all pediatric cases remains unknown. In this study, all cases of lobectomy by the 1WPM in children required conversion to thoracotomy. This indicates potential limitations in the applicability of the 1WPM in pediatric patients. Limitations based on physique remain an important consideration due to the infrequent use of the 1WPM. Further studies comparing populations with differences in physique are needed to address this gap. The retrospective design, absence of comparative subjects, and the small number of cases limited this study. In addition, we were not able to compare the different surgical methods under similar conditions. Since sublobar resection for small-lung cancers is widely performed, there are few cases of lobectomy without lymph node dissection. Further investigation with more cases is necessary.

Conclusion

In conclusion, for patients with lung disease, 1WPM lobectomy can be performed appropriately in selected cases, with a 35.7% conversion rate to conventional VATS or standard thoracotomy. It was a safe surgical procedure and no cases required urgent thoracotomy. In addition, pulmonary lobectomy by 1WPM can be applied to children and is considered to be a safe procedure that can be learned step by step. However, because of the possible limitations in applicability in neonatal cases with small physique, the indications and suitability of this procedure are probably selective.

Consent

Written informed consent was obtained from the patients for publication. A copy of the written consent form is available for review by the Editor-in-Chief of this journal upon request.

Provenance and peer review

Not commissioned, externally peer reviewed.

Ethical approval

A retrospective study that does not require ethical approval.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Author contribution

M.A., Y.H., T.K., and K.K. performed the surgical operations. M.A. wrote the manuscript with support from K.K., Y.H., and T.K. All authors discussed the results and contributed to the final manuscript.

Conflicts of interest

The authors have no conflicts of interest to declare.

Research registry UIN

Researchregistry4882.

Guarantor

Dr. Kichizo Kaga M.D., PhD. Department of Cardiovascular and Thoracic Surgery, Hokkaido University Faculty of Medicine, West-7, North-15, Kita-ku, Sapporo, Hokkaido, 060–8638, Japan.
  21 in total

Review 1.  One-port (uniportal) video-assisted thoracic surgical resections--a clear advance.

Authors:  Gaetano Rocco
Journal:  J Thorac Cardiovasc Surg       Date:  2012-06-27       Impact factor: 5.209

2.  Single-port video-assisted thoracoscopic left upper lobectomy.

Authors:  Diego Gonzalez-Rivas; Mercedes de la Torre; Ricardo Fernandez; Victor X Mosquera
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-08-09

3.  Single-incision video-assisted thoracoscopic lobectomy: initial results.

Authors:  Diego Gonzalez-Rivas; Marina Paradela; Eva Fieira; Carlos Velasco
Journal:  J Thorac Cardiovasc Surg       Date:  2011-08-25       Impact factor: 5.209

4.  Two decades of experience with thoracoscopic lobectomy in infants and children: standardizing techniques for advanced thoracoscopic surgery.

Authors:  Steven S Rothenberg; William Middlesworth; Angela Kadennhe-Chiweshe; Gudrun Aspelund; Keith Kuenzler; Robert Cowles; Lawrence Bodenstein; Saundra Kay; Kristin Shipman; Cathryn Rothenberg; Charles Stolar; Steven Stylianos
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2015-01-05       Impact factor: 1.878

5.  Uniportal video-assisted thoracoscopic lobectomy: two years of experience.

Authors:  Diego Gonzalez-Rivas; Marina Paradela; Ricardo Fernandez; Maria Delgado; Eva Fieira; Lucía Mendez; Carlos Velasco; Mercedes de la Torre
Journal:  Ann Thorac Surg       Date:  2012-12-05       Impact factor: 4.330

6.  Reduced port video-assisted thoracoscopic surgery using a needle scope for lung and mediastinal lesions.

Authors:  Kichizo Kaga; Yasuhiro Hida; Reiko Nakada-Kubota; Kazuto Ohtaka; Jun Muto; Keidai Ishikawa; Tatsuya Kato; Yoshiro Matsui
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-03

7.  Multiinstitutional analysis of single-port video-assisted thoracoscopic anatomical resection for primary lung cancer.

Authors:  Po-Kuei Hsu; Wei-Cheng Lin; Yin-Chun Chang; Mei-Lin Chan; Bing-Yen Wang; Chao-Yu Liu; Wen-Chien Huang; Chih-Hsun Shih; Chia-Chuan Liu
Journal:  Ann Thorac Surg       Date:  2015-03-29       Impact factor: 4.330

8.  Uniportal video-assisted thoracoscopic lobectomy: an alternative to conventional thoracoscopic lobectomy in lung cancer surgery?

Authors:  Jae Ho Chung; Yong Soo Choi; Jong Ho Cho; Hong Kwan Kim; Jhingook Kim; Jae Ill Zo; Young Mog Shim
Journal:  Interact Cardiovasc Thorac Surg       Date:  2015-03-03

9.  The two-incision approach for video-assisted thoracoscopic lobectomy: an initial experience.

Authors:  Jose Maria Borro; Diego Gonzalez; Marina Paradela; Mercedes de la Torre; Ricardo Fernandez; Maria Delgado; Jose Garcia; Eva Fieira
Journal:  Eur J Cardiothorac Surg       Date:  2010-06-16       Impact factor: 4.191

10.  Video-assisted thoracoscopic lobectomy in children: safety, efficacy, and risk factors for conversion to thoracotomy.

Authors:  Yong Won Seong; Chang Hyun Kang; Jin-Tae Kim; Hyun Jong Moon; In Kyu Park; Young Tae Kim
Journal:  Ann Thorac Surg       Date:  2013-02-28       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.